Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study.

Advani PG, Schonfeld SJ, Curtis RE, Dores GM, Linet MS, Sigel BS, Lam CJK, Tucker MA, Chanock SJ, Morton LM.

Leukemia. 2019 Jul 24. doi: 10.1038/s41375-019-0520-y. [Epub ahead of print] No abstract available.

PMID:
31341236
2.

Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.

Herr MM, Schonfeld SJ, Dores GM, Engels EA, Tucker MA, Curtis RE, Morton LM.

Blood Adv. 2019 Jul 9;3(13):1961-1969. doi: 10.1182/bloodadvances.2019030924.

3.

Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.

Morton LM, Dores GM, Schonfeld SJ, Linet MS, Sigel BS, Lam CJK, Tucker MA, Curtis RE.

JAMA Oncol. 2019 Mar 1;5(3):318-325. doi: 10.1001/jamaoncol.2018.5625.

PMID:
30570657
4.

Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014.

Teepen JC, Curtis RE, Dores GM, Berrington de Gonzalez A, van den Heuvel-Eibrink MM, Kremer LCM, Gilbert ES, van Leeuwen FE, Ronckers CM, Morton LM.

Leukemia. 2018 Dec;32(12):2580-2589. doi: 10.1038/s41375-018-0149-2. Epub 2018 May 24.

PMID:
29795414
5.

Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.

Herr MM, Schonfeld SJ, Dores GM, Withrow DR, Tucker MA, Curtis RE, Morton LM.

J Natl Cancer Inst. 2018 Nov 1;110(11):1248-1258. doi: 10.1093/jnci/djy052.

6.

Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers.

Withrow DR, Morton LM, Curtis RE, Schonfeld SJ, Berrington de González A.

JAMA Oncol. 2018 Mar 1;4(3):414-416. doi: 10.1001/jamaoncol.2017.4887. No abstract available.

7.

Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers.

Withrow DR, Morton LM, Curtis RE, Schonfeld SJ, Berrington de González A.

Breast Cancer Res Treat. 2017 Nov;166(1):299-306. doi: 10.1007/s10549-017-4410-6. Epub 2017 Jul 25.

PMID:
28744752
8.

Clustering of 770,000 genomes reveals post-colonial population structure of North America.

Han E, Carbonetto P, Curtis RE, Wang Y, Granka JM, Byrnes J, Noto K, Kermany AR, Myres NM, Barber MJ, Rand KA, Song S, Roman T, Battat E, Elyashiv E, Guturu H, Hong EL, Chahine KG, Ball CA.

Nat Commun. 2017 Feb 7;8:14238. doi: 10.1038/ncomms14238.

9.

Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.

Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF Jr, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, Joensuu H, Johannesen TB, Langmark F, Kaijser M, Pukkala E, Rajaraman P, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Aleman BM, Travis LB, Morton LM, van Leeuwen FE.

Radiat Res. 2017 Feb;187(2):186-195. doi: 10.1667/RR14453.1. Epub 2017 Jan 24.

10.

Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting.

Gierach GL, Curtis RE, Pfeiffer RM, Mullooly M, Ntowe EA, Hoover RN, Nyante SJ, Feigelson HS, Glass AG, Berrington de Gonzalez A.

JAMA Oncol. 2017 Feb 9;3(2):186-193. doi: 10.1001/jamaoncol.2016.3340. Epub 2016 Oct 6.

11.

Increased pancreatic cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Børge Johannesen T, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF Jr, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Morton LM, Fossa SD, Travis LB.

Br J Cancer. 2016 Sep 27;115(7):901-8. doi: 10.1038/bjc.2016.272. Epub 2016 Sep 6.

12.

Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.

Srour SA, Devesa SS, Morton LM, Check DP, Curtis RE, Linet MS, Dores GM.

Br J Haematol. 2016 Aug;174(3):382-96. doi: 10.1111/bjh.14061. Epub 2016 Apr 7. Erratum in: Br J Haematol. 2017 Apr;177(2):331.

13.

Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma.

Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF, Tucker MA, Morton LM.

Leukemia. 2016 May;30(5):1187-90. doi: 10.1038/leu.2015.248. Epub 2015 Sep 15. No abstract available.

14.

Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.

Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF Jr, Tucker MA, Morton LM.

J Clin Oncol. 2015 Oct 1;33(28):3096-104. doi: 10.1200/JCO.2014.60.2094. Epub 2015 Aug 3.

15.

Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers.

Shiels MS, Gibson T, Sampson J, Albanes D, Andreotti G, Beane Freeman L, Berrington de Gonzalez A, Caporaso N, Curtis RE, Elena J, Freedman ND, Robien K, Black A, Morton LM.

J Clin Oncol. 2014 Dec 10;32(35):3989-95. doi: 10.1200/JCO.2014.56.8220. Epub 2014 Nov 10.

16.

Increased stomach cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Fossa SD, Stovall M, van Leeuwen FE, Johannesen TB, Rajaraman P, Gilbert ES, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Travis LB, Morton LM.

Br J Cancer. 2015 Jan 6;112(1):44-51. doi: 10.1038/bjc.2014.552. Epub 2014 Nov 4.

17.

Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma.

Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Lamart S, Simon SL, Fraumeni JF Jr, Aleman BM, Curtis RE.

Haematologica. 2014 Oct;99(10):e193-6. doi: 10.3324/haematol.2014.108258. No abstract available.

18.

Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies.

Gibson TM, Park Y, Robien K, Shiels MS, Black A, Sampson JN, Purdue MP, Freeman LE, Andreotti G, Weinstein SJ, Albanes D, Fraumeni JF Jr, Curtis RE, Berrington de Gonzalez A, Morton LM.

J Clin Oncol. 2014 Dec 10;32(35):4004-11. doi: 10.1200/JCO.2014.56.8444. Epub 2014 Sep 29.

19.

Pancreatic cancer risk after treatment of Hodgkin lymphoma.

Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Fraumeni JF Jr, Aleman BM, Morton LM, Gilbert ES.

Ann Oncol. 2014 Oct;25(10):2073-9. doi: 10.1093/annonc/mdu287. Epub 2014 Jul 25.

20.

Network analysis of breast cancer progression and reversal using a tree-evolving network algorithm.

Parikh AP, Curtis RE, Kuhn I, Becker-Weimann S, Bissell M, Xing EP, Wu W.

PLoS Comput Biol. 2014 Jul 24;10(7):e1003713. doi: 10.1371/journal.pcbi.1003713. eCollection 2014 Jul.

21.

GWAS in a box: statistical and visual analytics of structured associations via GenAMap.

Xing EP, Curtis RE, Schoenherr G, Lee S, Yin J, Puniyani K, Wu W, Kinnaird P.

PLoS One. 2014 Jun 6;9(6):e97524. doi: 10.1371/journal.pone.0097524. eCollection 2014.

22.

The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults.

Morton LM, Onel K, Curtis RE, Hungate EA, Armstrong GT.

Am Soc Clin Oncol Educ Book. 2014:e57-67. doi: 10.14694/EdBook_AM.2014.34.e57. Review.

23.

Pooling prospective studies to investigate the etiology of second cancers.

Black A, Gibson TM, Shiels MS, Park Y, Robien K, Albanes D, Weinstein SJ, Freeman LE, Andreotti G, Purdue MP, Fraumeni JF, Hartge P, Tucker MA, Hoover RN, Cerhan JR, Zeleniuch-Jacquotte A, Curtis RE, Elena J, Sampson JN, Berrington de Gonzalez A, Morton LM.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1598-608. doi: 10.1158/1055-9965.EPI-14-0191. Epub 2014 May 15.

24.

Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.

Kutsenko A, Berrington de Gonzalez A, Curtis RE, Rajaraman P.

Cancer Causes Control. 2014 Jun;25(6):659-68. doi: 10.1007/s10552-014-0367-5. Epub 2014 Mar 30.

PMID:
24682745
25.

Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site.

Khalil MO, Morton LM, Devesa SS, Check DP, Curtis RE, Weisenburger DD, Dores GM.

Br J Haematol. 2014 Apr;165(1):67-77. doi: 10.1111/bjh.12730. Epub 2014 Jan 12.

26.

Prediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapy.

Lamart S, Imran R, Simon SL, Doi K, Morton LM, Curtis RE, Lee C, Drozdovitch V, Maass-Moreno R, Chen CC, Whatley M, Miller DL, Pacak K, Lee C.

Phys Med Biol. 2013 Dec 21;58(24):8739-53. doi: 10.1088/0031-9155/58/24/8739. Epub 2013 Dec 4.

27.

Stomach cancer risk after treatment for hodgkin lymphoma.

Morton LM, Dores GM, Curtis RE, Lynch CF, Stovall M, Hall P, Gilbert ES, Hodgson DC, Storm HH, Johannesen TB, Smith SA, Weathers RE, Andersson M, Fossa SD, Hauptmann M, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Pukkala E, Vaalavirta L, van den Belt-Dusebout AW, Fraumeni JF Jr, Travis LB, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2013 Sep 20;31(27):3369-77. doi: 10.1200/JCO.2013.50.6832. Epub 2013 Aug 26.

28.

Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer.

Kleinerman RA, Smith SA, Holowaty E, Hall P, Pukkala E, Vaalavirta L, Stovall M, Weathers R, Gilbert E, Aleman BM, Kaijser M, Andersson M, Storm H, Joensuu H, Lynch CF, Dores GM, Travis LB, Morton LM, Curtis RE.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):922-9. doi: 10.1016/j.ijrobp.2013.04.010. Epub 2013 May 22.

29.

Radiation dose to the esophagus from breast cancer radiation therapy, 1943-1996: an international population-based study of 414 patients.

Lamart S, Stovall M, Simon SL, Smith SA, Weathers RE, Howell RM, Curtis RE, Aleman BM, Travis L, Kwon D, Morton LM.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):694-701. doi: 10.1016/j.ijrobp.2013.03.014. Epub 2013 Apr 26.

PMID:
23628135
30.
31.

Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.

Morton LM, Dores GM, Tucker MA, Kim CJ, Onel K, Gilbert ES, Fraumeni JF Jr, Curtis RE.

Blood. 2013 Apr 11;121(15):2996-3004. doi: 10.1182/blood-2012-08-448068. Epub 2013 Feb 14.

32.

Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers.

Kim CJ, Freedman DM, Curtis RE, Berrington de Gonzalez A, Morton LM.

Leuk Lymphoma. 2013 Aug;54(8):1691-7. doi: 10.3109/10428194.2012.753543. Epub 2012 Dec 31.

33.

The association between cancer and amyotrophic lateral sclerosis.

Freedman DM, Curtis RE, Daugherty SE, Goedert JJ, Kuncl RW, Tucker MA.

Cancer Causes Control. 2013 Jan;24(1):55-60. doi: 10.1007/s10552-012-0089-5. Epub 2012 Oct 23.

34.

Patterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type.

Wu LC, Kleinerman RA, Curtis RE, Savage SA, de González AB.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1993-9. doi: 10.1158/1055-9965.EPI-12-0810. Epub 2012 Sep 10.

35.

The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status.

Schonfeld SJ, Curtis RE, Anderson WF, Berrington de González A.

Cancer Causes Control. 2012 Oct;23(10):1721-8. doi: 10.1007/s10552-012-0054-3. Epub 2012 Aug 24.

36.

Enabling dynamic network analysis through visualization in TVNViewer.

Curtis RE, Xiang J, Parikh A, Kinnaird P, Xing EP.

BMC Bioinformatics. 2012 Aug 16;13:204.

37.

Risk of treatment-related esophageal cancer among breast cancer survivors.

Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, Pukkala E, Weathers RE, Linet MS, Rajaraman P, Fraumeni JF Jr, Brown LM, van Leeuwen FE, Fossa SD, Johannesen TB, Langmark F, Lamart S, Travis LB, Aleman BM.

Ann Oncol. 2012 Dec;23(12):3081-91. doi: 10.1093/annonc/mds144. Epub 2012 Jun 27.

39.

Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States.

Little MP, Rajaraman P, Curtis RE, Devesa SS, Inskip PD, Check DP, Linet MS.

BMJ. 2012 Mar 8;344:e1147. doi: 10.1136/bmj.e1147.

40.
41.

Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.

Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM.

Blood. 2012 Jan 5;119(1):34-43. doi: 10.1182/blood-2011-04-347872. Epub 2011 Nov 15.

42.

TREEGL: reverse engineering tree-evolving gene networks underlying developing biological lineages.

Parikh AP, Wu W, Curtis RE, Xing EP.

Bioinformatics. 2011 Jul 1;27(13):i196-204. doi: 10.1093/bioinformatics/btr239.

43.

TVNViewer: an interactive visualization tool for exploring networks that change over time or space.

Curtis RE, Yuen A, Song L, Goyal A, Xing EP.

Bioinformatics. 2011 Jul 1;27(13):1880-1. doi: 10.1093/bioinformatics/btr273. Epub 2011 May 5.

44.

Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries.

Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E.

Lancet Oncol. 2011 Apr;12(4):353-60. doi: 10.1016/S1470-2045(11)70061-4.

45.

Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.

Morton LM, Curtis RE, Linet MS, Bluhm EC, Tucker MA, Caporaso N, Ries LA, Fraumeni JF Jr.

J Clin Oncol. 2010 Nov 20;28(33):4935-44. doi: 10.1200/JCO.2010.29.1112. Epub 2010 Oct 12.

46.

Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy.

Dores GM, Anderson WF, Beane Freeman LE, Fraumeni JF Jr, Curtis RE.

Br J Cancer. 2010 Sep 28;103(7):1081-4. doi: 10.1038/sj.bjc.6605877. Epub 2010 Sep 14.

47.

Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study.

Ghabach B, Anderson WF, Curtis RE, Huycke MM, Lavigne JA, Dores GM.

Breast Cancer Res. 2010;12(4):R54. doi: 10.1186/bcr2613. Epub 2010 Jul 23.

48.

Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer.

Lönn S, Gilbert ES, Ron E, Smith SA, Stovall M, Curtis RE.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):464-74. doi: 10.1158/1055-9965.EPI-09-0892.

49.

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.

Berrington de Gonzalez A, Curtis RE, Gilbert E, Berg CD, Smith SA, Stovall M, Ron E.

Br J Cancer. 2010 Jan 5;102(1):220-6. doi: 10.1038/sj.bjc.6605435. Epub 2009 Nov 24.

50.

Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States.

Boukheris H, Curtis RE, Land CE, Dores GM.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2899-906. doi: 10.1158/1055-9965.EPI-09-0638. Epub 2009 Oct 27.

Supplemental Content

Loading ...
Support Center